AUVEN THERAPEUTICS

auven-therapeutics-logo

Auven Therapeutics is a private equity company focused on the healthcare industry. The Companyโ€™s strategy is to acquire controlling ownership in promising therapeutic products or platforms. The value of these therapeutic assets is then significantly enhanced by global development programs prior to selling them as clinically and commercially validated products to established pharmaceutical companies. Auven Therapeutics has built a diversified portfolio of biologic and small molecule therape... utic candidates for a wide range of therapeutic indications. The Companyโ€™s existing pipeline addresses critical unmet medical needs in cancer, ophthalmic conditions, womenโ€™s health and orphan diseases. It has ownership of or a controlling interest in the therapeutic assets of ADC Therapeutics, Spirogen, Resolvyx and Kiacta, and a minority investment in Kolltan and Sprout Pharmaceuticals. Founded in 2007 by industry veterans Stephen Evans-Freke and Dr. Peter B. Corr, Auven Therapeutics Management L.L.L.P. is an investment advisor with its principal place of business in the US Virgin Islands. It manages Auven Therapeutics Holdings L.P., a private equity fund, which has its registered office and principal place of business in the British Virgin Islands. Auven Therapeutics Development, the operating company of Auven Therapeutics Holdings L.P. manages drug development from its bases in Lausanne, Switzerland, New York, USA and Hamilton, Bermuda. Auven Therapeutics is an investment advisor with its principal place of business in the US Virgin Islands. It manages Auven Therapeutics Holdings L.P., a private equity fund, which has its registered office and principal place of business in the British Virgin Islands. Auven Therapeutics Development, the operating company of Auven Therapeutics Management L.L.L.P. Holdings L.P. manages drug development from its bases in Lausanne, Switzerland, New York, USA and Hamilton, Bermuda.

#SimilarOrganizations #People #Financial #Website #More

AUVEN THERAPEUTICS

Social Links:

Industry:
Advice Health Care Therapeutics

Founded:
2007-01-01

Address:
Delray Beach, Florida, United States

Country:
United States

Website Url:
http://www.auventx.com

Total Employee:
101+

Status:
Active

Contact:
(340) 779-6908

Email Addresses:
[email protected]

Total Funding:
100 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Domain Not Resolving Apache


Similar Organizations

lannett-company-logo

Lannett Company

Lannett develops, manufactures, and distributes generic prescription pharmaceutical products in tablet.

montes-archimedes-acquisition-corp-logo

Montes Archimedes Acquisition Corp

Montes Archimedes Acquisition Corp is a Special Purpose Acquisition Company with a focus on the health care industry.

scout-bio-logo

Scout Bio

Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.

tivorsan-pharmaceuticals-logo

Tivorsan Pharmaceuticals

Tivorsan Pharmaceuticals is a protein therapeutics company that focuses on treating neuromuscular disorders.

Current Employees Featured

stephen-evans-freke_image

Stephen Evans-Freke
Stephen Evans-Freke Managing General Partner @ Auven Therapeutics
Managing General Partner

tomasz-sablinski_image

Tomasz Sablinski
Tomasz Sablinski MD, Head of Celtic Therapeutics Development @ Auven Therapeutics
MD, Head of Celtic Therapeutics Development
2008-01-01

michael-forer_image

Michael Forer
Michael Forer Partner @ Auven Therapeutics
Partner

Founder


peter-corr_image

Peter Corr

Investors List

ppd_image

PPD

PPD investment in Funding Round - Auven Therapeutics

Investments List

Date Company Article Money raised
2019-06-12 ADC Therapeutics Auven Therapeutics investment in Series E - ADC Therapeutics 76 M CHF
2017-10-23 ADC Therapeutics Auven Therapeutics investment in Series E - ADC Therapeutics 200 M USD
2016-10-27 ADC Therapeutics Auven Therapeutics investment in Series D - ADC Therapeutics 105 M USD
2015-09-02 ADC Therapeutics Auven Therapeutics investment in Series C - ADC Therapeutics 80 M USD
2013-10-16 ADC Therapeutics Auven Therapeutics investment in Series B - ADC Therapeutics 40 M USD
2012-03-26 ADC Therapeutics Auven Therapeutics investment in Series A - ADC Therapeutics 50 M USD
2010-01-20 Kolltan Pharmaceuticals Auven Therapeutics investment in Series B - Kolltan Pharmaceuticals 10 M USD
2009-10-22 Spirogen Auven Therapeutics investment in Private Equity Round - Spirogen 15 M USD
2009-10-12 Kolltan Pharmaceuticals Auven Therapeutics investment in Series A - Kolltan Pharmaceuticals 5 M USD
2008-07-31 Kolltan Pharmaceuticals Auven Therapeutics investment in Series A - Kolltan Pharmaceuticals 40 M USD

Official Site Inspections

http://www.auventx.com

Unable to get host informations!!!

Loading ...

More informations about "Auven Therapeutics" on Search Engine